Report of Foreign Issuer (6-k)
April 27 2017 - 7:06AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of April 2017
Commission
File Number 001-37381
MEDIGUS
LTD.
(Translation of registrant’s name into English)
Omer Industrial Park, No.
7A, P.O. Box 3030, Omer 8496500, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
__
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
__
EXPLANATORY
NOTE
On
April 27, 2017, Medigus Ltd. issued a press release titled: “First Ten MUSE
TM
Procedures for GERD Performed in
China as Part of CFDA Multi-Center Clinical Study.” A copy of this press release is furnished herewith as exhibit 99.1.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
MEDIGUS
LTD.
|
|
|
|
Date:
April 27, 2017
|
By:
|
/S/
Oded Yatzkan
|
|
|
Oded
Yatzkan
|
|
|
Chief
Financial Officer
|
EXHIBIT
INDEX
-4-
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024